|
|
|
|
|
EAE-MOG |
|
| |
|
| Model: |
MOG35-55 induced chronic EAE in C57BL/6 mice |
|
| Animal: |
C57BL/6 |
|
| Immunogen: |
MOG35-55 Peptide |
|
| Study duration: |
30 days (in life) |
|
| Pathological features: |
- |
Chronic model |
|
- |
Inflammatory Infiltration and de-myelination in CNS |
- |
Antibody response involves in pathology development |
- |
Large therapeutic window |
|
| Suitability: |
- |
De-myelination,axon damage,neuron regeneration and antibody intervention |
|
- |
Efficacy study |
|
| Parameter measures: |
- |
Body weight |
|
- |
clinical score |
- |
Histo-pathological assessment |
- |
Cytokine ELISA (optional) |
- |
RT-qPCR (optional) |
- |
IHC (optional) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
The Latest Generation of Auto Patch Clamp Platform Launched at HDB  |
|
---------------------- |
WuXi Biology/HD Biosciences Presented at Webinar of "New Technologies for Target Discovery and Validation" |
|
---------------------- |
HD Biosciences Merges with WuXi AppTec |
|
|
|
|
|
|
|
|
|
|
沪公网安备 31011502003320号